Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yObenzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor Related Orphan Receptor C2 Inverse Agonist

被引:26
|
作者
Schnute, Mark E. [1 ]
Wennerstal, Mattias [6 ]
Alley, Jennifer [2 ]
Bengtsson, Martin [6 ]
Blinn, James R. [4 ]
Bolten, Charles W. [5 ]
Braden, Timothy [5 ]
Bonn, Tomas [6 ]
Carlsson, Bo [6 ]
Caspers, Nicole [3 ]
Chen, Ming [3 ]
Choi, Chulho [3 ]
Collis, Leon P. [2 ]
Crouse, Kimberly [2 ]
Farnegardh, Mathias [6 ]
Fennell, Kimberly F. [3 ]
Fish, Susan [2 ]
Flick, Andrew C. [3 ]
Goos-Nilsson, Annika [6 ]
Gullberg, Hjalmar [6 ]
Harris, Peter K. [5 ]
Heasley, Steven E. [3 ]
Hegen, Martin [2 ]
Hromockyj, Alexander E. [5 ]
Hu, Xiao [5 ]
Husman, Bolette [6 ]
Janosik, Tomasz [6 ]
Jones, Peter [1 ]
Kaila, Neelu [1 ]
Kallin, Elisabet [6 ]
Kauppi, Bjorn [6 ]
Kiefer, James R. [4 ]
Knafels, John [3 ]
Koehler, Konrad [6 ]
Kruger, Lars [6 ]
Kurumbail, Ravi G. [3 ]
Kyne, Robert E., Jr. [3 ]
Li, Wei [2 ]
Lofstedt, Joakim [6 ]
Long, Scott A. [4 ]
Menard, Carol A. [3 ]
Mente, Scot
Messing, Dean
Meyers, Marvin J. [4 ]
Napierata, Lee [2 ]
Noteberg, Daniel [6 ]
Nuhant, Philippe [3 ]
Pelc, Matthew J. [4 ]
Prinsen, Michael J. [5 ]
Rhonnstad, Patrik [6 ]
机构
[1] Pfizer Inc, Med Design, Cambridge, MA 02139 USA
[2] Pfizer Inc, Inflammat & Immunol Res, Cambridge, MA 02139 USA
[3] Pfizer Inc, Med Design, Groton, CT 06340 USA
[4] Pfizer Inc, Worldwide Med Chem, St Louis, MO 63017 USA
[5] Pfizer Inc, Inflammat & Immunol Res, St Louis, MO 63017 USA
[6] Karo Pharma AB, S-11148 Stockholm, Sweden
关键词
ROR-GAMMA-T; NUCLEAR RECEPTOR; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; SECUKINUMAB; PSORIASIS; IDENTIFICATION; LIGANDS; DIFFERENTIATION; INFLAMMATION;
D O I
10.1021/acs.jmedchem.8b00392
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The nuclear hormone receptor retinoic acid receptor-related orphan C2 (RORC2, also known as ROR gamma t) is a promising target for the treatment of autoimmune diseases. A small molecule, inverse agonist of the receptor is anticipated to reduce production of IL-17, a key proinflammatory cytokine. Through a high-throughput screening approach, we identified a molecule displaying promising binding affinity for RORC2, inhibition of IL-17 production in Th17 cells, and selectivity against the related RORA and RORB receptor isoforms. Lead optimization to improve the potency and metabolic stability of this hit focused on two key design strategies, namely, iterative optimization driven by increasing lipophilic efficiency and structure-guided conformational restriction to achieve optimal ground state energetics and maximize receptor residence time. This approach successfully identified 3-cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide as a potent and selective RORC2 inverse agonist, demonstrating good metabolic stability, oral bioavailability, and the ability to reduce IL-17 levels and skin inflammation in a preclinical in vivo animal model upon oral administration.
引用
收藏
页码:10415 / 10439
页数:25
相关论文
共 32 条
  • [31] Structure-Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl) piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization
    Johnson, Mark
    Antonio, Tamara
    Reith, Maarten E. A.
    Dutta, Aloke K.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (12) : 5826 - 5840
  • [32] Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist
    Turnaturi, Rita
    Pasquinucci, Lorella
    Chiechio, Santina
    Grasso, Margherita
    Marrazzo, Agostino
    Amata, Emanuele
    Dichiara, Maria
    Prezzavento, Orazio
    Parenti, Carmela
    ACS CHEMICAL NEUROSCIENCE, 2020, 11 (07): : 999 - 1005